Drugs / Y-6
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06138834 | Nov 2023 → Nov 2024 | ischemic stroke, large artery stroke | Beijing Tiantan Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Y-6 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06138834 ↗ |
| Known as | Y-6 sublingual tablets | “To investigate the efficacy and safety of Y-6 sublingual tablets (cilostazol and dexborneol) compared with a placebo in the treatment of patients with acute ischaemic stroke...” PMID 40246318 ↗ Dec 2025 |